ROC Inc.

Raise More Awareness For Ovarian cancer With Free Downloadable Tools

February is ovarian cancer awareness month, it is an important time at Rare Ovarian Cancer Inc. (ROC Inc), we are passionate about bringing more attention to awareness and to highlight why funded research is so crucial. Ovarian cancer affects females of all ages from babies to post-menopausal women. Have you or someone you care about been impacted by ovarian cancer? Sharing your experience and knowledge with others can have a big impact. You can play an important part in raising awareness in your community about ovarian cancer to help we have created free printable resources posters, bunting and awareness ribbons […]

Australian researchers leading the way for a rare ovarian cancer.

Australian researchers at the Hudson Institute of Medical Research are leading the way for Granulosa Cell Tumour (GCT), a rare ovarian cancer. The researchers have an opportunity to undertake enhanced DNA testing called Whole Genome Sequencing (WGS) that could hold the answers for both subtypes of GCT adult GCT and Juvenile GCT. ROC Inc. aim is to raise the $30,000 needed to help get this testing underway. With no effective treatments for this recurrent cancer, we need to act now to save lives. Every dollar you can contribute counts. Donation Page Donate now or start your own fundraiser or team.

Tasha Armour CEO of ROC Inc, chats to Glenda of IWIB about ovarian cancer research and awareness.

Tasha Armour CEO of Rare Ovarian Cancer Incorporated (ROC Inc.) chats to Glenda of Illawarra Women In Business (IWIB) Tasha is the 2020 IWIB Outstanding Commitment to the Community Award winner sponsored by ANZ for the work she and ROC Inc team have achieved with the world’s first and largest research for Juvenile Granulosa Cell Tumour (jGCT) a rare ovarian cancer working with the Hudson Institute of Medical Research in Melbourne, Victoria. Tasha talks about ovarian cancer and how it affects females of all ages, her daughter being diagnosed at 16 years old with jGCT and there was no research. […]

Consumers working with researchers for a rare ovarian cancer.

It has been an exciting start to the second half of the year for a rare ovarian cancer called Granulosa Cell Tumour (GCT). Previously GCT has received very little research to be able to have standard protocols for treatment. Consumers from around the world are helping researchers at the Hudson Institute of Medical Research in Melbourne Australia to gain more insight into this rare disease with collected data information from the GCT Survivor Sisters and tumour tissue samples from patients. Kim Eroh the founder of the Facebook group GCT Survivor Sisters in 2012 created the group to be able to […]